Brief: CanSino Biologics Inc Sees FY Net Loss Attributable RMB335.0 Mln To RMB385.0 Mln
Jan 17 (Reuters) - CanSino Biologics Inc 688185.SS :
* SEES NET LOSS ATTRIBUTABLE FOR YEAR TO BE RMB335.0 MILLION
TO
RMB385.0 MILLION
* SEES REVENUE OF RMB825.0 MILLION TO RMB865.0 MILLION FOR
YEAR
Further company coverage: 688185.SS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025